Search Results - "M. Burge"

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer by Lee, B., Lipton, L., Cohen, J., Tie, J., Javed, A.A., Li, L., Goldstein, D., Burge, M., Cooray, P., Nagrial, A., Tebbutt, N.C., Thomson, B., Nikfarjam, M., Harris, M., Haydon, A., Lawrence, B., Tai, D.W.M., Simons, K., Lennon, A.M., Wolfgang, C.L., Tomasetti, C., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., Gibbs, P.

“…In early-stage pancreatic cancer, there are currently no biomarkers to guide selection of therapeutic options. This prospective biomarker trial evaluated the…”
Get full text

Conservative management of antenatally diagnosed cystic lung malformations by Ng, Christabella, Stanwell, Joanna, Burge, David M, Stanton, Michael P

“…Aim To review the outcome of all antenatally diagnosed conservatively managed congenital lung malformations (CLMs) managed at our centre. Methods All patients…”
Get full text

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial by Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, E.H., Watson, D.I., Ackland, S.P., Martin, J.M., Burge, M., Finch, R., Karapetis, C.S., Shannon, J., Nott, L.M., Varma, S., Marx, G., Falk, G.L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, B.M., Barbour, A., Simes, J., Walpole, E., Mai, T., Watson, D., Karapetis, C., Gebski, V., Barnes, L., Oostendorp, M., Wilson, K.

“…Patients with oesophageal/gastro-oesophageal junction adenocarcinoma (EAC) not showing early metabolic response (EMR) to chemotherapy have poorer survival and…”
Get full text

Randomised positive control trial of NSAID and antimicrobial treatment for calf fever caused by pneumonia by Mahendran, S. A., Booth, R., Burge, M., Bell, N. J.

“…One hundred and fifty-four preweaning calves were followed between May and October 2015. Calves were fitted with continuous monitoring temperature probes…”
Get full text

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma by Mercieca-Bebber, R, Barnes, E H, Wilson, K, Samoon, Z, Walpole, E, Mai, T, Ackland, S, Burge, M, Dickie, G, Watson, D, Leung, J, Wang, T, Bohmer, R, Cameron, D, Simes, J, Gebski, V, Smithers, M, Thomas, J, Zalcberg, J, Barbour, A P

“…AGITG DOCTOR was a randomised phase 2 trial of pre-operative cisplatin, 5 fluorouracil (CF) followed by docetaxel (D) with or without radiotherapy (RT) based…”
Get full text

Contemporary management and outcomes for infants born with oesophageal atresia by Burge, D. M., Shah, K., Spark, P., Shenker, N., Pierce, M., Kurinczuk, J. J., Draper, E. S., Johnson, P. R. V., Knight, M.

“…Background: Reports on the management and outcome of rare conditions, such as oesophageal atresia, are frequently limited to case series reporting…”
Get full text

Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial by Hamidovic, A, Khafaja, M, Brandon, V, Anderson, J, Ray, G, Allan, A M, Burge, M R

“…Many cigarette smokers express a desire to quit smoking, but ~85% of cessation attempts fail. In our attempt to delineate genetic modulators of smoking…”
Get full text

The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer by Barbour, Andrew P., Samra, Jaswinder S., Haghighi, Koroush S., Donoghoe, Mark W., Burge, Matthew, Harris, Marion T., Chua, Yu Jo, Mitchell, Jenna, O’Rourke, Nick, Chan, Howard, Gebski, Val J., Gananadha, Sivakumar, Croagh, Daniel G., Kench, James G., Goldstein, David

“…Background While combination therapy with nab -paclitaxel/gemcitabine ( nab -gem) is effective in pancreatic ductal adenocarcinoma (PDAC), its efficacy as…”
Get full text

Early onset metastatic colorectal cancer in Australia by Jalali, A., Smith, S., Kim, G., Wong, H., Lee, M., Yeung, J., Loft, M., Wong, R., Shapiro, J.D., Kosmider, S., Tie, J., Ananda, S., Ma, B., Burge, M., Jennens, R., Lee, B., Johns, J., Lim, L., Dean, A., Nott, L., Gibbs, P.

“…•Colorectal cancer (CRC) incidence and mortality rates have been increasing among adults under the age of 50-years (young patients, YP) and for uncertain…”
Get full text

Congenital lung malformations: an ongoing controversy by Peters, R T, Burge, D M, Marven, S S

“…Congenital lung malformations are rare lesions that are most commonly diagnosed antenatally. Management of such lesions, particularly those that are…”
Get full text

Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability–high (MSI-H) colorectal cancer: KEYNOTE-164 by Le, D., Kavan, P., Kim, T., Burge, M., Van Cutsem, E., Hara, H., Boland, P., Van Laethem, J., Geva, R., Taniguchi, H., Crocenzi, T., Sharma, M., Atreya, C., Diaz, L., Liang, L., Marinello, P., Dai, T., O’Neill, B.

Get full text

Stability, morphology and surface grain size patterns of channel bifurcation in gravel-cobble bedded anabranching rivers by Burge, Leif M.

“…This study presents the first detailed field‐based analysis of the morphology of bifurcations within anabranching cobble–gravel rivers. Bifurcations divide the…”
Get full text

Use of folfirinox chemotherapy in an Australasian population of pancreatic cancer by Jalali, A., Lee, M., Semira, C., Banks, S., Wong, H.-L., Ananda, S., Lipton, L., Shapiro, J.D., Cooray, P., Clarke, K., Burge, M., Wong, R., Shapiro, J.A., McLachlan, S.-A., Harris, M., Croagh, D., Tebbutt, N., Gibbs, P., Lee, B.

Get full text

Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma by Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, L., Watson, D.I., Ackland, S.P., Wills, V., Martin, J., Burge, M., Karapetis, C.S., Shannon, J., Nott, L.M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, M.

Get full text

The neuropsychiatric phenotype in Darier disease by Gordon-Smith, K., Jones, L.A., Burge, S.M., Munro, C.S., Tavadia, S., Craddock, N.

“…Summary Background  Darier disease (DD) is a rare autosomal dominantly inherited skin disorder in which co‐occurrence of neuropsychiatric abnormalities has…”
Get full text

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent by Lickliter, J D, Francesconi, A B, Smith, G, Burge, M, Coulthard, A, Rose, S, Griffin, M, Milne, R, McCarron, J, Yeadon, T, Wilks, A, Cubitt, A, Wyld, D K, Vasey, P A

“…Background: CYT997 is a novel microtubule inhibitor and vascular-disrupting agent with marked preclinical anti-tumour activity. Methods: This phase I…”
Get full text

Intrauterine death rate in gastroschisis following the introduction of an antenatal surveillance program: Retrospective observational study by Perry, Helen, Healy, Costa, Wellesley, Diana, Hall, Nigel J., Drewett, Melanie, Burge, David M., Howe, David T.

“…Aim To investigate whether an antenatal surveillance protocol including ultrasound and cardiotocograph monitoring reduces intrauterine death (IUD) in cases of…”
Get full text

Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice by Field, K., Shapiro, J., Wong, H.-L., Tacey, M., Nott, L., Tran, B., Turner, N., Ananda, S., Richardson, G., Jennens, R., Wong, R., Power, J., Burge, M., Gibbs, P.

“…Background Prior studies have suggested improved outcomes for cancer patients managed in private centres, despite universal healthcare within Australia. Aims…”
Get full text

An analysis of incidental and symptomatic pulmonary embolism (PE) in medical oncology patients by Thaker, DA, Douglas, E, Blazak, J, Xu, W, Hughes, B, Burge, M, Steinke, K, Wyld, D

“…Aim To determine the incidence of symptomatic versus incidental pulmonary embolism (PE) in oncology patients, characterize the nature and extent of incidental…”
Get full text

Errors of measurement for blood volume parameters: a meta-analysis by Gore, Christopher J, Hopkins, Will G, Burge, Caroline M

“…1 Department of Physiology, Australian Institute of Sport, Belconnen, Australian Capital Territory, Australia; 2 Health Science/Sport and Recreation, Auckland…”
Get full text